|
Sudeep Pharma Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
6623.87 Cr.
|
P/BV
|
9.13
|
Book Value (Rs.)
|
64.26
|
|
52 Week High/Low (Rs.)
|
795/544
|
FV/ML
|
1/1
|
P/E(X)
|
47.76
|
|
Bookclosure
|
|
EPS (Rs.)
|
12.28
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 162.67 | 124.92 |
| Total Income From Operations | 162.67 | 124.92 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | 70.48 | 57.63 |
| Increase/Decrease in Stocks | -9.54 | -15.31 |
| Employees Cost | 14.10 | 12.24 |
| Depreciation | 3.81 | 3.25 |
| Other Expenses | 32.17 | 26.48 |
| Total Expenses | 111.02 | 84.30 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 51.65 | 40.62 |
| Other Income | 10.17 | 5.16 |
| P/L Before Interest, Excpt. Items & Tax | 61.82 | 45.78 |
| Interest | 2.28 | 1.71 |
| P/L Before Exceptional Items & Tax | 59.53 | 44.07 |
| P/L Before Tax | 59.53 | 44.07 |
| Tax | 12.76 | 12.80 |
| P/L After Tax from Ordinary Activities | 46.78 | 31.27 |
| Net Profit/Loss For the Period | 46.78 | 31.27 |
| Minority Interest | -1.03 | -0.46 |
| Net P/L After Minority Interest & Share Of Associates | 45.75 | 30.81 |
| | | |
| Equity Share Capital | 9.72 | 9.72 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | 4.20 | 2.80 |
| Diluted EPS (Rs.) | 4.20 | 2.80 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | 4.20 | 2.80 |
| Diluted EPS (Rs.) | 4.20 | 2.80 |
| | | |
| PBITOE Margin (%) | 31.75 | 32.51 |
| PBTE Margin (%) | 36.59 | 35.28 |
| PBT Margin (%) | 36.59 | 35.28 |
| PAT Margin (%) | 28.75 | 25.03 |
| PAT After MI And SOA Margin (%) | 28.12 | 24.66 |
